Advertisement

Topics

[News] Discontinuation of melanoma combination immunotherapy

04:04 EDT 2 Sep 2017 | The Lancet

Patients with advanced melanoma might continue to benefit from combination immunotherapy even after treatment is stopped because of adverse events, a new study suggests.

Original Article: [News] Discontinuation of melanoma combination immunotherapy

NEXT ARTICLE

More From BioPortfolio on "[News] Discontinuation of melanoma combination immunotherapy"

Quick Search
Advertisement
 

Relevant Topic

Skin cancers
There are three main types of skin cancer: basal cell carcinoma, squamous cell carcinoma and malignant melanoma. Basal cell carcinoma Basal cell carcinoma, or BCC, is a cancer of the basal cells at the bottom of the epidermis. It’s very common ...